Pharmaceutical makers sending drug-spiked water to

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
151
Pharmaceutical makers sending drug-spiked water to treatment plants

http://www.ehn.org/are-drugs-getting-in-water...95865.html

Water treatment plants near drug makers are getting heavily drugged.
Wastewater treatment plants taking discharges from nearby pharmaceutical manufacturers have "substantially" higher concentrations of drugs in the water, according to a new national study.

In the most extreme example, an anti-fungal drug was found at levels 3,000 times higher at a treatment plant near a drug maker compared to treatment plants that don't accept drug maker discharge.

"Unfortunately, this is pretty typical," Jose Lozano, director of The Ithaca Area Wastewater Treatment Facility's Environmental Laboratory in New York, told EHN.

These plants were "not designed to treat these type of compounds," added Lozano, who was not involved in the study.

The research, led by federal scientists at the U.S. Geological Survey and published in Science of the Total Environment, is the first national study to examine drug loads sent to treatment plants from manufacturers and is the latest evidence that manufacturers are sending high loads of their products into our waterways—with the consequences on aquatic and human health still not fully understood.

"Modern wastewater treatment plants mostly reduce solids, and reduce bacteria. They were not engineered to deal with complex compounds," lead author of the study and physical scientist for the USGS, Tia-Marie Scott, told EHN.

Scott and colleagues tested 13 wastewater treatment plants receiving pharmaceutical discharges and six that did not. The plants were across the country—in a variety of urban and rural spots—however, as part of the study, they are anonymous.

They tested for 120 drugs and compounds formed when drugs break down. They found 33 drugs had concentrations "substantially higher" in plants near drug makers.

"There's a lot of variability," Scott said. "Some drugs stayed steady, while others pop up seasonally, like some drugs during flu season, for example."

In addition to the anti-fungal drug, they found: anti-histamines, diabetic medication, muscle relaxants, blood pressure drugs, insomnia drugs, anti-seizure medication and anti-inflammatories. Several of the drugs were found at levels hundreds of times higher near drug makers than at plants not receiving discharge.

Scientists are still trying to understand what the influx of pharmaceutical drugs into our environment may be doing. Much depends on the drug, the mixture and the dose; however, mixes of pharmaceuticals have previously been shown to disrupt the endocrine system of fish, feminized them, altered behavior and reproduction, changed growth, and increased liver sizes.

The authors point out, however, "many of the pharmaceuticals included in this study have not commonly been observed in the environment. Thus, little is currently known about potential environmental effects of these pharmaceuticals."

The Pharmaceutical Research and Manufacturers of America would not comment on the study. A spokesperson said via email that "manufacturing impact isn't the sort of thing we typically have the expertise to comment on."

Seeking solutions

ozano said his lab has found that keeping drug-tainted water in the treatment process for longer periods of time helps break down and rid the water of contaminants.

Like many wastewater plants, they let nature take its course — using microorganisms that break down and remove nutrients and organic material in wastewater. "The more time you allow it to spend in the system, you decrease the number of emerging contaminants," Lozano said. "They're more likely to be biodegraded, absorbed or modified."

But cities depend on treatment plants running quickly and efficiently, so this longer retention time "presents a challenge," Lozano said, adding they're experimenting with ways to optimize the process.

For treatment plants across the country trying to tackle emerging contaminants, money is an issue. For instance, many countries in Europe use ultraviolet light to disinfect water, a process that's proven quite effective for pharmaceuticals. But it consumes a lot of energy.

"If we were to implement that in the U.S., it would take a massive investment to solve the problem," Lozano said.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 127

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 184

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 342

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 342

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights and Updates on Apax Global Alpha Investments

Updated Category News Views 148

Understanding Apax Global Alpha Limited Apax Global Alpha Limited is a prominent player in the investment sector, recognized for its strategic engagements and robust portfolio. The company, trading under the ticker LSE:INVP, has continuous operations, which not only aim at capital growth but also seek to provide substantial value to stakeholders. Key Information Overview...

Continue Reading
Morgan Stanley's Insights on European Oil and Gas Stock Ratings

Updated Category News Views 187

Morgan Stanley's Updated Ratings on European Oil and Gas Stocks Morgan Stanley has recently updated its ratings on several notable European oil and gas companies, showcasing a mixed but insightful outlook for the sector as we head into 2025. The analysts have raised their overall view of the industry from a cautious stance to 'in-line,' reflecting compelling valuations...

Continue Reading
Defense Metals Corp Secures Funding Through Private Placement

Updated Category News Views 203

Defense Metals Corp Successfully Completes Private Placement Defense Metals Corp. (TSXV: DEFN) is excited to announce the closing of the second and final tranche of its private placement, designed to enhance its financial stability and operational capabilities. This recent tranche has brought in gross proceeds amounting to C$576,000, a notable addition to the ongoing...

Continue Reading
Understanding the Alexandria Real Estate Class Action Lawsuit

Updated Category News Views 193

Overview of the Securities Fraud Class Action The latest class action lawsuit against Alexandria Real Estate Equities, Inc. (NYSE: ARE) has raised significant concerns among investors. Recently announced, this lawsuit claims violations of federal securities laws amidst a notable decline in stock value, spurred by an impairment charge of $323.9 million. Implications of the...

Continue Reading
Czech Central Bank Poised for Potential Interest Rate Cuts

Updated Category News Views 112

Czech Central Bank's Potential for Rate Easing The Czech central bank finds itself at a pivotal moment as it considers resuming its monetary easing strategy, potentially as soon as next month. Board member Jan Prochazka has shed light on these developments, emphasizing that while easing could be on the table, uncertainties loom due to various domestic and external...

Continue Reading